Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • REGENERX BIOPHARMACEUTICALS Financial Overview

  • Income Statement: RGN

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 168,412.00 240,324.00 -71,912.00 -42.70%
    Gross Profit 149,016.00 219,127.00 -70,111.00 -47.05%
    Net Income Before Extra Items/Preferred Div -10.64 M -11.18 M 541,193.00 -5.09%
    Operating Income -10.79 M -11.84 M 1.06 M -9.81%
  • Cash Flow: RGN

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 7.95 M 45,706.00 7.90 M 99.42%
    Net Cash Flow - Investing -4.58 M 593,369.00 -5.17 M 112.95%
    Net Cash Flow/Operating Activities -10.57 M -8.81 M -1.76 M 16.68%
  • Balance Sheet: RGN

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 5.92 M 8.62 M -2.70 M -45.58%
    Total Liabilities 1.33 M 2.47 M -1.14 M -86.22%
    Shareholders Equity 4.60 M 6.15 M -1.56 M -33.85%
  • Key Ratios / Statistics: RGN

    • Valuation

      Price/Earnings (TTM) -5.62
      Price/Sales (TTM) 357.58
      Price/Book (MRQ) 20.51
      Price/Cash Flow (TTM) -4.46
    • Profitability

      Gross Margin 88.48
      Operating Margin -6,404.97
      Profit Margin -6,316.04
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 4.27
      Current Ratio (MRQ) 2.10
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -192.77
      Return on Assets (TTM) -166.08
      Return on Investments (TTM) -197.91